Pulling SEC filings + quote and writing the call…

Sally Beauty Holdings, Inc.
Next earnings Aug 3, 2026 (before open) · consensus $0.54 EPS, $949M rev
Last earnings -7.5% on 2026-05-11
Cheap, cash-generative value play: flat sales but 130bps of margin expansion, deleveraging and buybacks drive 32% EPS growth at 7.5x.
P/E (price / FY diluted EPS) 7.5 · FY2025
Quality fundamentals and an attractive price line up (~283% below fair value) — the rarer case where both the business and the entry look good.
SBH is a no-growth top line wrapped around a genuinely improving earnings engine, priced for pessimism. Revenue has slipped four straight years ($3.87B in FY2021 to $3.70B in FY2025, -0.4% YoY) and the store base is shrinking (4,422 vs 4,460, -38 net), with comparable sales up just 0.3% — this is not a grower. But the quality of earnings is rising sharply: gross margin expanded 70bps to 51.6%, operating margin 130bps to 8.9%, operating income grew 15.9% and net income jumped 27.7% to $196M. The MD&A credits the 'Fuel for Growth' efficiency program, promotional optimization and a 15.1% cut in unallocated/restructuring expense, while interest expense fell 15.7% on $119M of debt reduction — a self-reinforcing flywheel of cost-out plus deleveraging.
The capital-return math is what makes the stock interesting. EPS of $1.89 (+32.2%) outran net income growth because the share count fell 4.3% via $54M of buybacks (5.0M shares retired). Operating cash flow of $275M less $102M capex leaves ~$173M of free cash flow against a $1.39B market cap — roughly a 12% FCF yield — funding both debt paydown and repurchases. ROE is a strong 24.7%, and long-term debt fell 12% to $875M with cash up 38% to $149M, so the balance sheet, while still levered at 2.62x liabilities/equity, is moving the right way.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 6:21 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.87B | $3.82B | $3.73B | $3.72B | $3.70B |
| Gross profit | $1.95B | $1.92B | $1.90B | $1.89B | $1.91B |
| Operating income | $418M | $338M | $325M | $283M | $328M |
| Net income | $240M | $184M | $185M | $153M | $196M |
| Diluted EPS | $2.10 | $1.66 | $1.69 | $1.43 | $1.89 |
| Net margin | 6.2% | 4.8% | 5.0% | 4.1% | 5.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q2 FY26 10-Q (period Mar 31) details H1 sales/margin progress
Q2 FY26 10-Q (period Mar 31) details H1 sales/margin progress
Announced executive/director leadership change (Item 5.02)
Disclosed officer or board appointment/departure (Item 5.02)
Q1 FY26 10-Q filed covering quarter ended Dec 2025
Q1 FY26 10-Q filed covering quarter ended Dec 2025
Annual meeting vote results: directors elected, say-on-pay, auditor
Proxy: board slate, executive pay, auditor ratification for annual meeting
FY25 10-K: net income +28%, margins up 70-130bps, $119M debt reduction
Sources: SEC EDGAR (CIK 0001368458, latest 10-Q filed 2026-05-11) · EODHD · Proprietary analysis · as of 6/30/2026, 10:21:23 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-08 | Platz Marlo Michelle Cormier Former SVP & CFO | Exercise | 31.0K @ $9.09 | $282K |
| 2026-06-08 | Platz Marlo Michelle Cormier Former SVP & CFO | Exercise | 11.7K @ $11.78 | $138K |
| 2026-06-08 | Platz Marlo Michelle Cormier Former SVP & CFO | Sell | 42.8K @ $12.70 | $543K |
| 2026-04-21 | Cox Erin Nealy Director | Exercise | 50.5K | |
| 2026-01-22 | Bishop Rachel Rothe Director | Exercise | 14.5K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.